Scientific Advisory Board About APDA Scientific Advisory BoardScientific Advisory BoardThe Board comprises scientists with nationally recognized expertise in a variety of leading edge research areas within the field of Parkinson’s disease.APDA grants are awarded through a competitive application process and reviewed by APDA’s Scientific Advisory Board (SAB). A rigorous review and scoring process of the applications is conducted by the SAB when it convenes annually to review the proposals. In order to be considered for funding, only applications which meet the highest quality are recommended by to the APDA Board of Directors for. Scoring of the grants includes three major areas of criteria including: overall significance and impact in the field of Parkinson’s disease, the appropriateness of the principal investigator and the academic and scientific environment for the proposed project, and the feasibility of the proposed budget and time period for completion.APDA Scientific Advisory Board: (Back row L-R) Joel S. Perlmutter, MD, Washington University School of Medicine; Dennis W. Dickson, MD, Mayo Clinic, Jacksonville; Un Jung Kang, MD, Columbia University College of Physicians and Surgeons; Richard Myers, PhD, Boston University School of Medicine; David G. Standaert, MD, PhD, Chairman of the APDA SAB, University of Alabama at Birmingham; Patrick McDermott, Chairman, APDA Board of Directors; Clemens R. Scherzer, MD, Harvard Medical School and Brigham & Women’s Hospital; Vivek K. Unni, MD, PhD, Oregon Health & Science University. (Front row L-R); Mary Maral Mouradian, MD, Rutgers Robert Wood Johnson Medical School: Marie Hélène Saint-Hilaire, MD, FRCP (C), Boston University School of Medicine; Leslie A. Chambers, President & CEO, APDA; Rebecca Gilbert, MD, PhD, VP and Chief Scientific Officer, APDA; J. Timothy Greenamyre, MD, PhD, University of Pittsburgh Medical Center. (Not pictured); Mahlon R. DeLong, MD, Emory University School of Medicine; Laura Marsh, MD, Michael E. DeBakey VA Medical Center; Jill L. Ostrem, MD, University of California San Francisco; Evan Yale Snyder, MD, PhD, The Burnham Institute. David G. Standaert, MD, PhD, Chairman John N. Whitaker Professor and Chair of Neurology University of Alabama at Birmingham, School of Medicine, Birmingham, AL Mahlon R. DeLong, MD Timmie Professor of Neurology Emory University School of Medicine, Atlanta, GA Dennis W. Dickson, MD Professor of Laboratory Medicine & Pathology Mayo Clinic, Jacksonville, FL J. Timothy Greenamyre, MD, PhD Love Family Professor & Vice-Chair of Neurology University of Pittsburgh Medical Center, Pittsburgh, PA Un Jung Kang, MD H. Houston Merritt Professor of Neurology Columbia University College of Physicians and Surgeons, New York, NY Laura Marsh, MD Professor of Psychiatry and Neurology Michael E. DeBakey, VA Medical Center, Houston, TX Mary Maral Mouradian, MD William Dow Lovett Professor of Neurology Rutgers Robert Wood Johnson Medical School, Piscataway, NJ Richard Myers, PhD Director, Genome Science Institute Professor, Dept. of Neurology Boston University School of Medicine, Boston, MA Jill Ostrum, MD Professor of Neurology Division Chief, UCSF Movement Disorder and Neuromodulation Center Weill Institute for Neurosciences, University of California San Francisco University of California San Francisco Joel S. Perlmutter, MD Elliot Stein Family Professor of Neurology Professor of Radiology, Neurobiology, Physical Therapy & Occupational Therapy Washington University School of Medicine, St Louis, MO Marie Hélène Saint-Hilaire, MD, FRCP (C) Professor of Neurology Boston University School of Medicine, Boston, MA Clemens R. Scherzer, MD Associate Professor of Neurology Harvard Medical School, Cambridge, MA Evan Yale Snyder, MD, PhD Director, Stem Cell & Regeneration Program The Burnham Institute, La Jolla, CA Vivek K. Unni, MD, PhD Assistant Professor, Oregon Health & Science University Department of Neurology Jungers Center for Neurosciences Research Parkinson Center of Oregon, Portland, ORShare this page:
